[DUOX1: a future for the treatment of resistant allergic asthma?]

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Medecine sciences : M/S

• Publication date

  2017-08-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1051/medsci/20173308016PMID 28945561
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DUOX1 mediates persistent epithelial EGFR activation, mucous cell metaplasia, and airway remodeling during allergic asthma.

  2016cited by this paper
• Airway epithelial dual oxidase 1 mediates allergen-induced IL-33 secretion and activation of type 2 immune responses.

  2016cited by this paper
• [Innate lymphoid cells: new players of the mucosal immune response].

  2014cited by this paper
• Peroxide-dependent sulfenylation of the EGFR catalytic site enhances kinase activity.

  2011cited by this paper
• The sentinel role of the airway epithelium in asthma pathogenesis

  2011cited by this paper
• Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases

  2008cited by this paper

• No citing papers are available for this paper.